Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
45.85    0.05 (0.11%)
Bid:
45.60
Ask:
45.90
Spread: 0.30 (0.658%)
Market Cap: £290.17m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Director/PDMR Shareholding

28 Jun 2017 16:03

RNS Number : 4761J
Marston's PLC
28 June 2017
Β 

Notification of interests of Directors and Persons Discharging Managerial Responsibilities

28 June 2017

The Company announces that on 28 June 2017 the Director listed below exercised an award over ordinary shares in the Company under the Company's 2014 Long Term Incentive Plan, which had been granted on 25 June 2014.

Shares were sold by the Director to the extent necessary to fund tax and NICs arising on the exercise as noted below.

Director

Aggregate number of shares in respect of which LTIP Award exercised*

Β 

Number of shares which were sold by the Director on 28 June 2017 at a price of Β£1.240118 per share

Andrew Andrea

57,907

27,313

Β 

\* The award granted on 25 June 2014 consisted of an LTIP Award and a "Linked Award", and a separate Approved Option over 20,876 shares at an exercise price of Β£1.437 per share. The Approved Option was released by the Director as part of the exercise process so that, in accordance with the rules of the LTIP the LTIP Award and Linked Award are capable of exercise to the extent vested.

The relevant notification set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

Enquiries: Anne-Marie Brennan, Group Secretary, Marston's PLC, +44 (0)1902 329163

Β 

1.

Details of PDMR / PCA (person closely associated)

Β 

(a)

Name

Andrew Andrea

Β 

(b)

Position/status

Director and PDMR (Chief Financial and Corporate Development Officer)

Β 

(c)

Initial notification/ amendment

Initial notification

Β 

2.

Details of the issuer

Β 

(a)

Name

Marston's PLC

Β 

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

(a)

Description of the financial instrument

Ordinary shares of 7.375p each

Β 

ISIN GB00B1JQDM80

Β 

(b)

Nature of the transaction

Exercise of award under the Long Term Incentive Plan and sale of shares to fund tax associated tax liability

Β 

(c)

Price(s) and volume(s)

Β 

Price(s)

Volume(s)

N/A

57,907

Β£1.240118

27,313

(d)

Aggregated information

Β 

Aggregated volume price

n/a single transaction

Β 

n/a single transaction

Β 

(e)

Date of the transaction

Β 

2017-06-28

(f)

Place of the transaction

Β 

London Stock Exchange, Main Market (XLON)

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DSHEASKPAEFXEFF
Date   Source Headline
26th Jun 20231:08 pmRNSDirector/PDMR Shareholding
25th May 20238:16 amRNSDirector/PDMR Shareholding
24th May 20238:48 amRNSDirector/PDMR Shareholding
16th May 20237:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 1 APRIL 2023
31st Mar 20237:00 amRNSAmendment and extension of debt facilities
22nd Mar 202310:19 amRNSHolding(s) in Company
24th Jan 20232:01 pmRNSResult of AGM
24th Jan 20237:00 amRNSTrading for the 16-week period to 21 January 2023
10th Jan 20233:07 pmRNSBlock listing Interim Review
6th Jan 20233:11 pmRNSHolding(s) in Company
3rd Jan 20239:42 amRNSHolding(s) in Company
21st Dec 20225:05 pmRNSConfirmation of Covenant Amendments
21st Dec 20222:34 pmRNSAnnual Financial Report
14th Dec 20229:00 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSPreliminary Results for 52 weeks ended 1 Oct 2022
5th Dec 202212:31 pmRNSConfirmation of Final Results announcement date
30th Nov 202210:46 amRNSHolding(s) in Company
28th Nov 202212:55 pmRNSChange to Final Results date and update on trading
28th Nov 20229:59 amRNSHolding(s) in Company
25th Nov 202212:04 pmRNSHolding(s) in Company
17th Nov 20229:14 amRNSHolding(s) in Company
17th Nov 20227:09 amRNSDirector Declaration re: New Directorship
10th Nov 202210:47 amRNSHolding(s) in Company
9th Nov 20228:15 amRNSHolding(s) in Company
3rd Nov 20224:25 pmRNSHolding(s) in Company
3rd Nov 20223:05 pmRNSHolding(s) in Company
11th Oct 20227:00 amRNSTrading update for the 52 weeks to 1 October 2022
6th Oct 20229:31 amRNSCorrection re Holding(s) in Company
5th Oct 202212:15 pmRNSHolding(s) in Company
12th Sep 20229:43 amRNSDirector/PDMR Shareholding
5th Sep 202212:27 pmRNSDirector/PDMR Shareholding
2nd Sep 202210:14 amRNSDirector/PDMR Shareholding
31st Aug 20222:51 pmRNSHolding(s) in Company
27th Jul 20227:00 amRNSTrading update for the 42 weeks to 23 July 2022
11th Jul 202212:03 pmRNSBlock listing Interim Review
7th Jul 20229:55 amRNSHolding(s) in Company
29th Jun 20228:45 amRNSDirector/PDMR Shareholding
13th Jun 20228:30 amRNSDirector/PDMR Shareholding
30th May 20222:14 pmRNSHolding(s) in Company
25th May 20228:54 amRNSHolding(s) in Company
20th May 202210:15 amRNSDirector/PDMR Shareholding
19th May 20227:00 amRNSInvestor Meet Company Presentation
18th May 20227:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 2 APRIL 2022
5th Apr 202212:39 pmRNSHolding(s) in Company
30th Mar 20228:28 amRNSDirector/PDMR Shareholding
28th Mar 20229:49 amRNSHolding(s) in Company
17th Mar 202210:18 amRNSHolding(s) in Company
8th Mar 202210:06 amRNSHolding(s) in Company
7th Mar 20227:00 amRNSDirectorate Change
3rd Mar 20229:45 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.